Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helena R. Chang

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Journal of Proteome Research|June 16, 2009
Mass spectrometry (LC-MS/MS) site-mapping of N-glycosylated membrane proteins for breast cancer biomarkersStephen A Whelan, Ming Lu, Jianbo He, et al.
Journal of Proteome Research|September 1, 2012
Mass spectrometry (LC-MS/MS) identified proteomic biosignatures of breast cancer in proximal fluidStephen A Whelan, Jianbo He, Ming Lu, et al.
Human Pathology|September 5, 2006
Decreased expression of annexin A1 is correlated with breast cancer development and progression as determined by a tissue microarray analysisDejun Shen, Farzad Nooraie, Yahya Elshimali, et al.
Oncotarget|April 19, 2017
CD24 Expression and differential resistance to chemotherapy in triple-negative breast cancerXinyu Deng, Sophia Apple, Hong Zhao, et al.
International Journal of Oncology|December 5, 2006
Detection of breast cancer biomarkers in nipple aspirate fluid by SELDI-TOF and their identification by combined liquid chromatography-tandem mass spectrometryJianbo He, Jeffrey Gornbein, Dejun Shen, et al.
International Journal of Proteomics|November 24, 2011
Proteomic-based biosignatures in breast cancer classification and prediction of therapeutic responseJianbo He, Stephen A Whelan, Ming Lu, et al.
Biochemical and Biophysical Research Communications|November 30, 2004
Loss of annexin A1 expression in human breast cancer detected by multiple high-throughput analysesDejun Shen, Helena R Chang, Zugen Chen, et al.
Human Pathology|November 17, 2010
Higher levels of GATA3 predict better survival in women with breast cancerNam K Yoon, Erin L Maresh, Dejun Shen, et al.
Oncotarget|November 5, 2016
ERBB2 mutation is associated with a worse prognosis in patients with CDH1 altered invasive lobular cancer of the breastZheng Ping, Gene P Siegal, Shuko Harada, et al.
Cancer Research Communications|August 25, 2023
A Pilot Study of Neoadjuvant Nivolumab, Ipilimumab, and Intralesional Oncolytic Virotherapy for HER2-negative Breast CancerVina P Nguyen, Katie M Campbell, Theodore S Nowicki, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Journal of Proteome Research|June 16, 2009
Mass spectrometry (LC-MS/MS) site-mapping of N-glycosylated membrane proteins for breast cancer biomarkersStephen A Whelan, Ming Lu, Jianbo He, et al.
Journal of Proteome Research|September 1, 2012
Mass spectrometry (LC-MS/MS) identified proteomic biosignatures of breast cancer in proximal fluidStephen A Whelan, Jianbo He, Ming Lu, et al.
Human Pathology|September 5, 2006
Decreased expression of annexin A1 is correlated with breast cancer development and progression as determined by a tissue microarray analysisDejun Shen, Farzad Nooraie, Yahya Elshimali, et al.
Oncotarget|April 19, 2017
CD24 Expression and differential resistance to chemotherapy in triple-negative breast cancerXinyu Deng, Sophia Apple, Hong Zhao, et al.
International Journal of Oncology|December 5, 2006
Detection of breast cancer biomarkers in nipple aspirate fluid by SELDI-TOF and their identification by combined liquid chromatography-tandem mass spectrometryJianbo He, Jeffrey Gornbein, Dejun Shen, et al.
International Journal of Proteomics|November 24, 2011
Proteomic-based biosignatures in breast cancer classification and prediction of therapeutic responseJianbo He, Stephen A Whelan, Ming Lu, et al.
Biochemical and Biophysical Research Communications|November 30, 2004
Loss of annexin A1 expression in human breast cancer detected by multiple high-throughput analysesDejun Shen, Helena R Chang, Zugen Chen, et al.
Human Pathology|November 17, 2010
Higher levels of GATA3 predict better survival in women with breast cancerNam K Yoon, Erin L Maresh, Dejun Shen, et al.
Oncotarget|November 5, 2016
ERBB2 mutation is associated with a worse prognosis in patients with CDH1 altered invasive lobular cancer of the breastZheng Ping, Gene P Siegal, Shuko Harada, et al.
Cancer Research Communications|August 25, 2023
A Pilot Study of Neoadjuvant Nivolumab, Ipilimumab, and Intralesional Oncolytic Virotherapy for HER2-negative Breast CancerVina P Nguyen, Katie M Campbell, Theodore S Nowicki, et al.
Pageof 4